Acanthosis nigricans: metabolic interrelations inherent to the polycystic ovary syndrome

被引:2
作者
de Avila, Marcio Augusto Pinto [1 ]
Borges, Lunna Perdigao [2 ]
Paez, Marina Silva [1 ]
Bruno, Ricardo Vasconcellos [1 ]
Nardi, Antonio Egidio [2 ,4 ]
de Pessoa, Ana Carolina Machado [3 ,5 ]
Palmeira, Evelyn de Souza [6 ]
机构
[1] Univ Fed Rio Janeiro, Fac Med, Dept Ginecol & Obstet, Rio De Janeiro, Brazil
[2] Univ Fed Rio Janeiro, Inst Med, Grad Estat, Rio De Janeiro, Brazil
[3] Univ Fed Rio Janeiro, Inst Med, Dept Metodos, Rio De Janeiro, Brazil
[4] Univ Fed Rio Janeiro, Inst Ginecol, Setor Ginecol Endocrina, Rio De Janeiro, Brazil
[5] Univ Fed Rio Janeiro, Dept Psiquiat, Rio De Janeiro, Brazil
[6] Univ Fed Rio Janeiro, Curso Grad Med, Rio De Janeiro, Brazil
来源
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA | 2014年 / 36卷 / 09期
关键词
Acanthosis nigricans; Polycystic ovary syndrome; Insulin resistance; Metabolic syndrome X; Obesity;
D O I
10.1590/SO100-720320140005078
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
PURPOSE: To establish the prevalence of acanthosis nigricans (AN) within the context of polycystic ovary syndrome (PCOS) and its associations with obesity, insulin resistance, insulinemia, and metabolic syndrome (MS). METHODS: A cross-sectional prospective study was conducted on 100 patients with PCOS diagnosed according to the Rotterdam Consensus (2003). The skin test included, in addition to the detection of the presence of AN, the presence of hirsutism (score >= 8) and acne. In addition to clinical and biochemical data, we investigated cardiovascular risk factors present in MS such as abdominal circumference, obesity, hypertension and HDL and triglyceride levels. Insulin resistance was determined by the HOMA-IR test. RESULTS: The prevalence of AN (53%) was significantly correlated with hirsutism (p=0.02), body mass index (p<0.01), basal insulinemia (p<0.01), (HOMA-IR) (p<0.01), and MS (p<0.01). The prevalence of MS reached 36% and was significantly associated only with AN (p<0.01). Although diabetes mellitus was absent, there was a significant association of altered HOMA-IR (p<0.01) with MS (p<5%) and AN (p<0.01). CONCLUSION: AN is part of the severe phenotypic profile of PCOS as an additional predictable sign of the risks of cardiovascular disease.
引用
收藏
页码:410 / 415
页数:6
相关论文
共 50 条
  • [1] Associations of acanthosis nigricans with metabolic abnormalities in polycystic ovary syndrome women with normal body mass index
    Dong, Zhe
    Huang, Jia
    Huang, Lili
    Chen, Xiaoli
    Yin, Qianqian
    Yang, Dongzi
    JOURNAL OF DERMATOLOGY, 2013, 40 (03) : 188 - 192
  • [2] Acanthosis nigricans and the metabolic syndrome
    Karadag, Ayse Serap
    You, Yi
    Danarti, Retno
    Al-Khuzaei, Safaa
    Chen, WenChieh
    CLINICS IN DERMATOLOGY, 2018, 36 (01) : 48 - 53
  • [3] A SYNDROME OF HYPERANDROGENISM, INSULIN RESISTANCE, AND ACANTHOSIS NIGRICANS ASSOCIATED WITH POLYCYSTIC-OVARY-SYNDROME - CLINICAL AND LABORATORY FEATURES
    TAKETANI, Y
    MIZUNO, M
    HORMONE RESEARCH, 1990, 33 : 27 - 30
  • [4] Relationship of acanthosis nigricans with metabolic syndrome in obese children
    Daye, Munise
    Eklioglu, Beray Selver
    Atabek, Mehmet Emre
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (12) : 1563 - 1568
  • [5] Acanthosis nigricans: Clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome
    Charnvises, K
    Weerakiet, S
    Tingthanatikul, Y
    Wansumrith, S
    Chanprasertyothin, S
    Rojanasakul, A
    GYNECOLOGICAL ENDOCRINOLOGY, 2005, 21 (03) : 161 - 164
  • [6] Prevalence of the metabolic syndrome in women with polycystic ovary syndrome
    Bregieiro Fernandes Costa, Laura Olinda
    Ribeiro Viana, Aline de Oliveira
    de Oliveira, Monica
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2007, 29 (01): : 10 - 17
  • [7] Metabolic syndrome in adolescents with polycystic ovary syndrome
    Vrbikova, Jana
    Zamrazilova, Hana
    Sedlackova, Barbora
    Sanajderova, Marta
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (10) : 820 - 822
  • [8] Metabolic syndrome in patients with the polycystic ovary syndrome
    Panidis, Dimitrios
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2013, 8 (06) : 559 - 568
  • [9] The metabolic effects of polycystic ovary syndrome
    Bednarek-Tupikowska, Grazyna
    Bucyk, Barbara
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2008, 10 (03) : 769 - 774
  • [10] The metabolic syndrome in polycystic ovary syndrome
    Essah, Paulina A.
    Wickham, Edmond P.
    Nestler, John E.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2007, 50 (01) : 205 - 225